Cargando…

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaufmann, Stefan H. E., Dockrell, Hazel M., Drager, Nick, Ho, Mei Mei, McShane, Helen, Neyrolles, Olivier, Ottenhoff, Tom H. M., Patel, Brij, Roordink, Danielle, Spertini, François, Stenger, Steffen, Thole, Jelle, Verreck, Frank A. W., Williams, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632681/ https://www.ncbi.nlm.nih.gov/pubmed/29046674 http://dx.doi.org/10.3389/fimmu.2017.01203

Ejemplares similares

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
por: Dockrell, Hazel M., et al.
Publicado: (2022)

First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment
por: Vasina, Daria V., et al.
Publicado: (2019)

Cross-laboratory evaluation of multiplex bead assays including independent common reference standards for immunological monitoring of observational and interventional human studies
por: van Meijgaarden, Krista E., et al.
Publicado: (2018)

Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis
por: Smith, Steven G., et al.
Publicado: (2009)

Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
por: Tkachuk, A. P., et al.
Publicado: (2017)

Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells
por: Tanner, Rachel, et al.
Publicado: (2019)

Assay optimisation and technology transfer for multi-site immuno-monitoring in vaccine trials
por: Smith, Steven G., et al.
Publicado: (2017)

Immunological Outcomes of New Tuberculosis Vaccine Trials: WHO Panel Recommendations
por: Hanekom, Willem A, et al.
Publicado: (2008)

Safety and Immunogenicity of the GamTBvac, the Recombinant Subunit Tuberculosis Vaccine Candidate: A Phase II, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study
por: Tkachuk, Artem P., et al.
Publicado: (2020)

Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018)

Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines
por: Smith, Steven G., et al.
Publicado: (2015)

Local Pulmonary Immunological Biomarkers in Tuberculosis
por: Morrison, Hazel, et al.
Publicado: (2021)

Countering the stray magnetic field of the CUSP trap by using additional coils
por: Thole, Jelle
Publicado: (2016)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
por: Smith, Steven G, et al.
Publicado: (2010)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
por: Morrison, Hazel, et al.
Publicado: (2023)

An imaging mass cytometry immunophenotyping panel for non-human primate tissues
por: Niewold, Paula, et al.
Publicado: (2022)

Working together toward vaccines and biomarkers in the real world
por: Dockrell, Hazel M.
Publicado: (2017)

Discovery of pathway-independent protein signatures associated with clinical outcome in human cancer cohorts
por: Konaté, Mariam M., et al.
Publicado: (2022)

The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development
por: Roordink, Danielle, et al.
Publicado: (2021)

Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
por: Ottenhoff, Tom H. M., et al.
Publicado: (2012)

Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis
por: Dijkman, Karin, et al.
Publicado: (2020)

Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
por: Dockrell, Hazel M., et al.
Publicado: (2022)

Combination of Cytokine Responses Indicative of Latent TB and Active TB in Malawian Adults
por: Hur, Yun-Gyoung, et al.
Publicado: (2013)

MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
por: Verreck, Frank A. W., et al.
Publicado: (2009)

Correction: MVA.85A Boosting of BCG and an Attenuated, phoP Deficient M. tuberculosis Vaccine Both Show Protective Efficacy Against Tuberculosis in Rhesus Macaques
por: Verreck, Frank A. W., et al.
Publicado: (2011)

The human immune response to tuberculosis and its treatment: a view from the blood
por: Cliff, Jacqueline M, et al.
Publicado: (2015)

What Have We Learnt about BCG Vaccination in the Last 20 Years?
por: Dockrell, Hazel M., et al.
Publicado: (2017)

Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TB
por: Jackson-Sillah, Dolly, et al.
Publicado: (2013)

The 2020 SLAS Discovery Top 10: Advancing the Science of Drug Discovery
por: Campbell, Robert M.
Publicado: (2021)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
por: Dijkman, Karin, et al.
Publicado: (2021)

Meningitis in an Irish community
por: Gillespie, S H, et al.
Publicado: (1988)

CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
por: Smirnova, Tatiana, et al.
Publicado: (2021)

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts
por: Duffy, Fergal J., et al.
Publicado: (2018)

Air leaks following pulmonary resection for lung cancer: is it a patient or surgeon related problem?
por: Elsayed, H, et al.
Publicado: (2012)

Thanks to our reviewers of 2019 and call to review in 2020!
por: Stoffers, Jelle
Publicado: (2020)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014)

Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection
por: Betts, Gareth, et al.
Publicado: (2012)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
por: McShane, Helen
Publicado: (2011)

Introducción al pensamiento crítico
por: McShane, Philip
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_70ahn75atj6h475p3qdskr745o